Clinical Trials Logo

Clinical Trial Summary

This is a multi-center, double-blind, randomized, placebo-controlled study to determine the safety, tolerability, and pharmacodynamics of SDI-118 in a once daily (QD) dosing regimen on male and female study participants reporting with cogntive decline and who in remission from depression.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05212116
Study type Interventional
Source Syndesi Therapeutics
Contact
Status Withdrawn
Phase Phase 1
Start date September 16, 2021
Completion date March 11, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04211467 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
Recruiting NCT05220228 - Prucalopride and Cognition in Recovered Depression Early Phase 1
Completed NCT05111665 - Decentering and Relapse/Recurrence in MBCT for Depression in Adults N/A
Recruiting NCT02821975 - Cognitive Computer Training in Patients With Depression N/A